GO:2000766 negative regulation of cytoplasmic translation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000766 describes any process that stops, prevents, or reduces the frequency, rate, or extent of cytoplasmic translation.
• Negative regulation of cytoplasmic translation is a key adaptive response to stress, allowing cells to conserve energy and selectively translate stress-response proteins.
• m6A modification of mRNA can negatively regulate translation by switching transcripts from polysomes to P-bodies via IGF2BP3.
• RBM43 controls PGC1α translation and a PGC1α-STING signaling axis, linking translational repression to metabolic and immune regulation.
• SMYD5 methylation of rpL40 links ribosomal output to gastric cancer, showing how translational control influences tumorigenesis.
• Dysregulation of cytoplasmic translation is implicated in cancer, neurodegeneration, and ribosomopathies [4,5,7].
Description
Cytoplasmic translation is the process by which ribosomes synthesize proteins from mRNA templates in the cytoplasm. Negative regulation of cytoplasmic translation (GO:2000766) encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of this translation. This regulation is essential for cellular homeostasis, allowing cells to rapidly adapt to stress, nutrient deprivation, and other environmental changes by globally suppressing protein synthesis while selectively translating specific mRNAs. Researchers study this process to understand how cells balance protein production, how dysregulation contributes to diseases such as cancer and neurodegeneration, and how to manipulate translation for therapeutic benefit [4,5,7]. Key mechanisms include phosphorylation of eukaryotic initiation factor 2α (eIF2α) during the integrated stress response, m6A-dependent mRNA remodeling, and ribosome modifications. Understanding these pathways provides insights into fundamental cell biology and identifies potential drug targets.
negative regulation of cytoplasmic translation At A Glance
| GO ID | GO:2000766 |
|---|---|
| GO term | negative regulation of cytoplasmic translation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Downregulation of protein synthesis in the cytoplasm |
| Related processes | Stress response, mRNA stability, ribosome quality control |
| Key regulators | eIF2α kinases, m6A readers, ribosomal proteins |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders |
What Is GO:2000766?
GO:2000766, negative regulation of cytoplasmic translation, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of cytoplasmic translation. This biological process includes mechanisms that inhibit the initiation, elongation, or termination phases of protein synthesis in the cytoplasm, often in response to cellular stress or signaling cues.
Why Is negative regulation of cytoplasmic translation Important in Cell Biology?
Negative regulation of cytoplasmic translation is critical for cellular survival under stress, as it prevents the accumulation of misfolded proteins and conserves resources. It also shapes the proteome by selectively allowing translation of specific mRNAs, such as those encoding transcription factors like ATF4, which drive adaptive responses. Dysregulation of this process is linked to cancer progression, where increased translation supports proliferation [4,5], and to neurodegenerative diseases characterized by aberrant protein aggregation. Understanding the mechanisms of translational repression offers opportunities for therapeutic intervention in these conditions.
• Enables rapid adaptation to stress by globally reducing protein synthesis.
• Conserves energy and amino acids during nutrient deprivation.
• Prevents proteotoxic stress by limiting misfolded protein accumulation.
• Shapes gene expression by selectively translating stress-response mRNAs.
• Regulates cell growth and proliferation, with implications for cancer [4,5].
• Modulates immune signaling through metabolic regulators like PGC1α.
• Influences synaptic plasticity and memory via local translation control.
• Contributes to circadian rhythms by regulating clock protein synthesis.
• Plays a role in viral infection by controlling viral protein production.
• Is a target for therapeutic intervention in cancer and neurodegeneration [4,7].
What Happens During negative regulation of cytoplasmic translation?
Initiation Inhibition via eIF2α Phosphorylation
In simple terms: Cells can halt protein production at the very first step by modifying a key initiation factor.
Phosphorylation of eukaryotic initiation factor 2α (eIF2α) by stress-activated kinases such as PERK, PKR, GCN2, and HRI prevents the recycling of eIF2-GDP to eIF2-GTP, thereby blocking translation initiation. This leads to global translational repression while allowing selective translation of mRNAs with upstream open reading frames, such as ATF4, which promote stress adaptation.
m6A-Dependent mRNA Remodeling
In simple terms: Chemical tags on mRNA can send transcripts to storage compartments, reducing their translation.
N6-methyladenosine (m6A) modification of mRNAs can negatively regulate translation by promoting their relocation from polysomes to P-bodies. The m6A reader IGF2BP3 recognizes methylated transcripts and mediates this switch, leading to reduced translation of target mRNAs. This mechanism fine-tunes gene expression in response to developmental or environmental cues.
Ribosome Modification and Output Control
In simple terms: Changes to ribosomal proteins can alter how efficiently ribosomes make proteins.
Methylation of ribosomal protein rpL40 by SMYD5 affects ribosomal output and links translational capacity to gastric cancer. Such modifications can reduce overall translation rates and influence cell fate decisions, highlighting the role of ribosome heterogeneity in translational control.
Stress Granule Dynamics and mRNA Storage
In simple terms: Cells can pack mRNAs into temporary granules to pause translation during stress.
Stress granules are cytoplasmic aggregates of stalled translation initiation complexes and mRNAs that form upon stress. NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination, thereby influencing the availability of mRNAs for translation. This reversible storage allows cells to resume translation after stress relief.
Regulation by RNA-Binding Proteins
In simple terms: Proteins that bind RNA can directly block or reduce translation of specific messages.
RNA-binding proteins such as RBM43 control the translation of specific mRNAs like PGC1α, impacting metabolic and immune signaling. By binding to target transcripts, these proteins can inhibit translation initiation or elongation, contributing to the negative regulation of cytoplasmic translation.
Key Genes Involved in GO:2000766 negative regulation of cytoplasmic translation
The following genes and proteins are key players in the negative regulation of cytoplasmic translation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF2AK3 (PERK) | Phosphorylates eIF2α to inhibit translation initiation during ER stress | Integrated stress response, cancer, neurodegeneration |
| EIF2AK2 (PKR) | Phosphorylates eIF2α in response to viral infection | Antiviral defense, immune regulation |
| EIF2AK4 (GCN2) | Phosphorylates eIF2α during amino acid deprivation | Nutrient sensing, metabolic stress |
| EIF2AK1 (HRI) | Phosphorylates eIF2α in heme deficiency | Erythropoiesis, hemoglobinopathies |
| IGF2BP3 | m6A reader that promotes mRNA switch from polysomes to P-bodies | m6A-dependent translational repression, cancer |
| SMYD5 | Methylates rpL40 to regulate ribosomal output | Gastric cancer, ribosome biology |
| RBM43 | RNA-binding protein controlling PGC1α translation | Metabolic regulation, STING signaling |
| NS1 binding protein | Regulates stress granule dynamics by inhibiting p62 ubiquitination | Stress granule clearance, neurodegeneration |
| TRIM24 | Cytoplasmic TRIM24 promotes Wnt/β-catenin signaling | Colorectal cancer proliferation |
| DTX3L | Mediates TIRR nuclear export and degradation | DNA repair, PARP inhibitor sensitivity |
| ATF4 | Transcription factor selectively translated upon eIF2α phosphorylation | Stress adaptation, autophagy, apoptosis |
| P62 (SQSTM1) | Autophagy receptor regulated by NS1 binding protein | Stress granule clearance, protein aggregation |
| PGC1α (PPARGC1A) | Master regulator of mitochondrial biogenesis, translation controlled by RBM43 | Metabolic disorders, immune signaling |
| rpL40 (RPL40) | Ribosomal protein methylated by SMYD5 | Ribosome function, gastric cancer |
| TIRR (TP53RK) | Protein involved in DNA repair, regulated by DTX3L | PARP inhibitor sensitivity, cancer |
| Circular RNAs | Can be translated in a cap-independent manner, regulated by structured elements | Non-canonical translation, cancer |
How Is negative regulation of cytoplasmic translation Regulated?
Negative regulation of cytoplasmic translation is tightly controlled by multiple signaling pathways. The integrated stress response (ISR) is a major regulator, where phosphorylation of eIF2α by kinases such as PERK, PKR, GCN2, and HRI leads to global translational attenuation. This pathway is modulated by phosphatases like PP1c that dephosphorylate eIF2α to restore translation. Additionally, mTOR signaling promotes translation initiation; its inhibition by rapamycin or nutrient deprivation reduces translation. m6A modification and RNA-binding proteins provide transcript-specific regulation [2,6]. Stress granule dynamics also influence translation by sequestering mRNAs.
negative regulation of cytoplasmic translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIM24 | Colorectal cancer | Knockout in HCT116 cells |
| SMYD5 | Gastric cancer | Knockout in AGS cells |
| IGF2BP3 | Cancer, m6A regulation | Knockout in HeLa cells |
| NS1 binding protein | Neurodegeneration | Knockout in SH-SY5Y cells |
| RBM43 | Metabolic disorders | Knockout in HepG2 cells |
Cancer
Dysregulated translation contributes to cancer by supporting rapid proliferation and survival. Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt/β-catenin signaling. SMYD5 methylation of rpL40 links ribosomal output to gastric cancer, suggesting that targeting translational machinery could be therapeutic. m6A-dependent translational repression by IGF2BP3 affects oncogene expression.
Neurodegeneration
Impaired stress granule clearance and translational repression are implicated in neurodegenerative diseases. NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination; dysfunction leads to protein aggregation. Persistent eIF2α phosphorylation is observed in Alzheimer's disease and prion disorders.
Metabolic Disorders
RBM43 controls PGC1α translation and a PGC1α-STING signaling axis, linking translational control to metabolic regulation and immune response. Dysregulation may contribute to obesity and insulin resistance.
Ribosomopathies
Mutations in ribosomal proteins or modifications like SMYD5-mediated rpL40 methylation can disrupt ribosome function and translation, leading to diseases such as Diamond-Blackfan anemia.
From negative regulation of cytoplasmic translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate global translation? | Knockout cell line + puromycin incorporation assay |
| Does mutation in gene X affect stress granule formation? | Point mutation knock-in cell line + immunofluorescence |
| Does gene X control specific mRNA translation? | Tagged knock-in (e.g., HA-tag) + Ribo-seq |
| Does overexpression of gene X repress translation? | Overexpression cell line + polysome profiling |
| Does gene X interact with ribosomal proteins? | Knock-in with proximity labeling (BioID) + mass spectrometry |
| Does gene X affect drug sensitivity? | Knockout + drug screen (e.g., PARP inhibitors) |
How to Study the negative regulation of cytoplasmic translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Genome-wide ribosome occupancy | Identifying translated ORFs and changes in translation efficiency |
| Polysome profiling | Distribution of mRNAs across polysomes | Assessing global translation and mRNA partitioning |
| Puromycin incorporation | Global protein synthesis rate | Validating translational repression |
| Immunofluorescence | Localization of proteins and granules | Visualizing stress granules and P-bodies |
| Western blot | Protein expression levels | Detecting eIF2α phosphorylation |
| qRT-PCR | mRNA levels | Distinguishing transcriptional from translational regulation |
| Mass spectrometry | Proteome-wide protein abundance | Identifying downstream effects of translational control |
| CRISPR screen | Gene essentiality and drug sensitivity | Discovering regulators of translation |
Ribosome Profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of translating ribosomes at codon resolution. It can quantify changes in translation efficiency upon negative regulation, such as eIF2α phosphorylation or m6A modification [3,6].
Polysome Profiling
Polysome profiling separates mRNAs by the number of ribosomes bound, allowing assessment of translation initiation and elongation. It is used to study the switch from polysomes to P-bodies during translational repression.
Puromycin Incorporation Assay
Puromycin incorporates into nascent polypeptides, and its detection via immunofluorescence or Western blot measures global translation rates. This method is widely used to confirm negative regulation of cytoplasmic translation.
Immunofluorescence and Live Imaging
Imaging of stress granules, P-bodies, and ribosomal markers allows visualization of translational repression dynamics in single cells. Co-localization of mRNAs with these granules indicates storage.
How CRISPR Can Be Used to Study GO:2000766 negative regulation of cytoplasmic translation
Knockout
CRISPR knockout of genes involved in negative regulation of cytoplasmic translation, such as EIF2AK3 or IGF2BP3, can reveal their roles in stress response and disease. For example, knocking out TRIM24 in colorectal cancer cells reduces proliferation.
Point Mutation
Introducing point mutations, such as phosphorylation-deficient eIF2α (S51A), allows precise dissection of signaling pathways. This can be achieved via CRISPR knock-in of mutant alleles.
Knock-in
Tagged knock-in of genes like RBM43 with HA or GFP enables tracking of protein localization and interactions. Knock-in of m6A reader mutants can clarify their role in translational repression [2,6].
Overexpression
Overexpression of negative regulators, such as NS1 binding protein, can suppress translation and affect stress granule clearance. This is useful for gain-of-function studies.
How EDITGENE Supports negative regulation of cytoplasmic translation Research
Researchers studying negative regulation of cytoplasmic translation-related genes often need to determine whether a candidate gene is causally involved in translational control, stress response, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of cytoplasmic translation research.
Frequently Asked Questions About negative regulation of cytoplasmic translation
What is negative regulation of cytoplasmic translation?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of protein synthesis in the cytoplasm, often in response to stress.
What genes are involved in negative regulation of cytoplasmic translation?
Key genes include EIF2AK3 (PERK), EIF2AK2 (PKR), EIF2AK4 (GCN2), IGF2BP3, SMYD5, RBM43, and NS1 binding protein [2,3,5,6,7].
How does eIF2α phosphorylation inhibit translation?
Phosphorylation of eIF2α prevents recycling of eIF2-GDP to eIF2-GTP, blocking translation initiation and reducing global protein synthesis.
What is the role of m6A in translational repression?
m6A modification can recruit readers like IGF2BP3 to switch mRNAs from polysomes to P-bodies, reducing their translation.
Which diseases are linked to dysregulated cytoplasmic translation?
Cancer, neurodegeneration, metabolic disorders, and ribosomopathies are associated with aberrant translational control [2,4,5,7].
How can I study negative regulation of cytoplasmic translation?
Methods include Ribo-seq, polysome profiling, puromycin incorporation, and imaging of stress granules [3,6,7].
What is the integrated stress response?
A cellular pathway that phosphorylates eIF2α to globally repress translation while selectively translating stress-response mRNAs like ATF4.
Can CRISPR be used to study translational control?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise manipulation of genes involved in translational regulation [4,5,8].
What are stress granules?
Cytoplasmic aggregates of stalled translation complexes and mRNAs that form during stress and can be cleared by NS1 binding protein.
How does SMYD5 regulate translation?
SMYD5 methylates ribosomal protein rpL40, affecting ribosomal output and linking translation to gastric cancer.
Conclusion
Negative regulation of cytoplasmic translation (GO:2000766) is a fundamental biological process that controls protein synthesis in response to stress and signaling cues. Key mechanisms include eIF2α phosphorylation, m6A-dependent mRNA remodeling, and ribosome modifications. Dysregulation of this process contributes to cancer, neurodegeneration, and metabolic diseases. Advanced CRISPR models and multi-omics methods are essential for dissecting these pathways and developing therapeutic strategies.
References
- 1. Chen CK et al.. 2021. Structured elements drive extensive circular RNA translation.. Mol Cell 81(20):4300-4318.e13 PMID: 34437836
- 2. Dumesic PA et al.. 2025. RBM43 controls PGC1α translation and a PGC1α-STING signaling axis.. Cell Metab 37(3):742-757.e8 PMID: 39965564
- 3. Harding HP et al.. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells.. Mol Cell 6(5):1099-108 PMID: 11106749
- 4. Wang Y et al.. 2025. Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt/β-catenin signaling.. Nat Commun 16(1):8598 PMID: 41022821
- 5. Park J et al.. 2024. SMYD5 methylation of rpL40 links ribosomal output to gastric cancer.. Nature 632(8025):656-663 PMID: 39048817
- 6. Shan T et al.. 2023. m(6)A modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3.. Mol Cell 83(24):4494-4508.e6 PMID: 38016476
- 7. Jeon P et al.. 2024. NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination.. Nat Commun 15(1):10925 PMID: 39738171
- 8. Ye Q et al.. 2024. DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity.. Nat Commun 15(1):10596 PMID: 39632881
